Jean-Paul Moatti has been Chairman of the Board and Chief Executive Officer of IRD since 11 March 2015. In accordance with the statutory provisions that govern this Public Scientific and Technological Establishment (EPST), he is both Chairman of the Institute’s Board of Directors and CEO of the institution.
Jean-Paul Moatti is 63 and was, until his appointment, Professor of Economics at Aix-Marseille University (AMU) and Director of the joint research unit IRD/Inserm/AMU “Economic and Social Sciences of Health and the Processing of Medical Information” (SESSTIM).
During his career, Professor Moatti has held a number of national scientific positions of responsibility. He was Director of the thematic multi-institution public health institute (ISP) of the Life Sciences and Health Alliance (Aviesan), which now coordinates all public research in this field. He was also a member of the national CNRS committee and of the Board of Directors of Aix-Marseille University, and Vice-President of the Inserm scientific committee. In addition, he was President of the scientific committee of the National Institute for Prevention and Health Education (INPES) and of the sectoral scientific committee “Research in Public Health and Human and Social Sciences” of the National Agency for Research on AIDS and Hepatitis (ANRS). He is currently a member of the scientific committee of the Institute for Radiological Protection and Nuclear Safety (IRSN) and of the School for Advanced Studies in Public Health (EHESP).
After starting his career at the Center for the Assessment of Nuclear Protection at the Atomic Energy Commission (CEA) and Electricité de France (EDF), and following a thesis in Economic Sciences at Paris 1 University in the field of environmental risks, Jean-Paul Moatti turned towards health economics, initially as a researcher at Inserm, then as a professor at Aix-Marseille University.
From the 1990s onwards, Jean-Paul Moatti focused his research on developing countries and in particular has contributed to the fight against the major pandemics HIV/AIDS and malaria, to access to essential drugs, strengthening health systems and reducing health and social inequalities. His research, which is always conducted in partnership with scientists in the countries in question, has led him to work in the field in Cameroon, Côte d’Ivoire, Mali, Palestine, South Africa, and in countries in North Africa and the Middle East.
It has also led him to hold international responsibilities as a member of the Advisory Committee for Health Research (ACHR) attached to the Director General of the World Health Organization (WHO) of the Scientific Expert Panel attached to the Director of UNAIDS, and of the Global Health Advisory Committee of the Open Society Foundations. He has also been advisor on economic and social affairs to the Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM).
Jean-Paul Moatti is the author of over 350 articles in scientific reviews and publications on both economic and social sciences and biomedical disciplines and public health. He is, for example, the co-author of the article published in Nature Medicine in 2003 demonstrating for the first time not only the virological and clinical, but also the economic feasibility of access to combination therapies for HIV/AIDS in developing countries. Jean-Paul Moatti is also the author of several publications, including “Le principe de prévention. Le culte de la santé et ses dérives” (“The principle of prevention. The cult of health and its excesses”), published in 2009 with the sociologist Patrick Peretti-Watel by Editions du Seuil.